Meeting
2018 Gastrointestinal Cancers Symposium
The antidiarrheal efficacy of a proprietary amino acid mixture in gastroenteropancreatic neuroendocrine patients.
Authors
Aman Chauhan
University of Kentucky, Lexington, KY
Aman Chauhan , Rachel C Miller , Qian Yu , Bilal Aslam , Heidi Weiss , Lowell Brian Anthony
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 509)
DOI
10.1200/JCO.2018.36.4_suppl.509
Abstract #
509
Poster Bd #
P9
Abstract Disclosures
Similar Posters
Poster
2018 Palliative and Supportive Care in Oncology Symposium
The antidiarrheal efficacy of a proprietary amino acid mixture in neuroendocrine tumor (NET) patients.
First Author: Laura Luque
Poster
2020 Gastrointestinal Cancers Symposium
The antidiarrheal efficacy of a proprietary amino acid mixture (enterade) in neuroendocrine tumor (NET) patients: Updated data.
First Author: Aman Chauhan
Poster
2023 ASCO Gastrointestinal Cancers Symposium
ETCTN 10450: A phase I trial of peposertib and lutetium 177 DOTATATE in well-differentiated somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
First Author: Aman Chauhan
Poster
2016 Gastrointestinal Cancers Symposium
Blood neuroendocrine tumor gene cluster analysis to predict somatostatin analog response.
First Author: Mark S. Kidd